A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit.

Eilan Al-HershDina AbushanabFouad AbouNahiaDaniel RainkieMoza Al HailPalli Valapila AbdulroufWessam El-KassemDaoud Al-Badriyeh

Published in: Journal of pharmaceutical policy and practice (2024)

This is the first literature economic evaluation of caffeine for AOP. Despite increasing the cost of therapy, HD maintenance caffeine seems to be a cost-effective alternative to LD caffeine in Qatar. Our results support the recent global trends of increased use of HD caffeine for AOP in NICU.

Keyphrases

low dose
preterm infants
systematic review
obstructive sleep apnea
stem cells
chemotherapy induced